Radical cytoreductive surgery combined with platinums-carboplatin and cisplatin chemotherapy for advanced ovarian cancer
Authors:
- M. OhwaraMOM. Ohwara
- I. SekiguchiISI. Sekiguchi
- I. SatoISI. Sato
- 1 January 1999
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 9 (1) , 54-60
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Combined Cisplatin and Carboplatin Chemotherapy for Treatment of Advanced Epithelial Ovarian CancerGynecologic Oncology, 1995
- Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinomaCancer, 1994
- Extensive Primary Cytoreductive Surgery for Advanced Epithelial Ovarian CancerGynecologic Oncology, 1994
- Peritoneal Implant Elimination during Cytoreductive Surgery for Ovarian Cancer: Impact on SurvivalGynecologic Oncology, 1993
- Meta-analysis of surgery in advanced ovarian carcinoma: Ismaximum cytoreductive surgery an independent determinant of prognosis?American Journal of Obstetrics and Gynecology, 1992
- Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancerEuropean Journal of Cancer, 1992
- Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA studyGynecologic Oncology, 1990
- Primary surgical therapy of ovarian cancer: How much and whenGynecologic Oncology, 1990
- Long-Term Follow-Up of Patients with Advanced Ovarian Carcinoma Treated with Debulking Surgery and Chemotherapy Consisting of Cisplatin, Doxorubicin, and CyclophosphamideOncology, 1990
- Intensive Surgical and Chemotherapeutic Management of Advanced Ovarian CancerSurgical Clinics of North America, 1978